US · RPTX · BIOTECHNOLOGY
Repare Therapeutics Inc. (RPTX) intrinsic value and stock valuation
$2.65as of 2026-01-28 · Mkt cap 74.32M
Data updated · price as of 2026-01-28
- P/E
- Pro
- P/B
- Pro
- P/S
- Pro
Price history
Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.
Repare Therapeutics Inc. DCF and intrinsic value
InvestorsCraft values RPTX with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from RPTX’s statements →
Is it expensive?
Each multiple against its own 15-year range, or against peers where no history is available
Peers
Same-industry companies, ranked by market cap
Peer comparison
The peer comparison table is shown only to users with a Pro subscription.
Financials
Statements by fiscal year
About Repare Therapeutics Inc.
Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that focuses on genomic instability, including DNA damage repair. Its lead product candidate is RP-3500, an oral small molecule inhibitor for the treatment of solid tumors with specific DNA damage repair-related genomic alterations. It is also developing RP-6306, which is under Phase I clinical trial for tumors with genetic alterations characterized by CCNE1 amplification; and Polymerase Theta program, a SL target associated with BRCA mutations and other genomic alterations. The company was incorporated in 2016 and is headquartered in Montreal, Canada.
- CEO
- Steve Forte CPA
- Employees
- 129
- Beta
- 1.04
Explore
Frequently asked questions
What is the intrinsic value of Repare Therapeutics Inc. (RPTX)?
InvestorsCraft does not currently publish an intrinsic value for RPTX. How the IC value is calculated.
Is RPTX undervalued?
InvestorsCraft does not publish an undervaluation signal for RPTX at this time.
How is the intrinsic value calculated?
InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.
How often is this page updated?
Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Aug 18, 2026.
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.